PCOS Management of Androgenetic Alopecia

    January 2024
    A. Savitha, R. Raghunatha Reddy
    Image of study
    TLDR Hair loss in women with PCOS is linked to high androgen levels but the relationship is unclear.
    Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder among women of reproductive age, affecting 4-20% of Indian women, though the actual prevalence may be higher. Common symptoms include menstrual irregularities, hirsutism, acne, and hair loss, with female pattern hair loss (FPHL) being a notable sign of hyperandrogenism in PCOS. FPHL is a progressive, non-scarring type of alopecia affecting 20-30% of women with PCOS, often accompanied by other symptoms like hirsutism and acne. The relationship between hair loss and androgen excess in women with PCOS remains inconsistent and unclear. Recent guidelines continue to use "alopecia" as a diagnostic term for hyperandrogenism in PCOS.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 93 results

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 7 months ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

      community Spironolactine Update: 2 months (34, Female)

      in Female  23 upvotes 7 years ago
      A female user's experience using Spironolactone to treat Female Pattern Hair Loss (FPHL) and Androgenic Alopecia, as well as discussing the effectiveness of the drug at different dosages.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

    Similar Research

    6 / 1000+ results